Tending to Neglected Diseases

Bringing new drugs, diagnostics, and vaccines to market for diseases afflicting under-served populations outside the U.S. is a challenge normally left to Government and charitable non-profits. Diseases without a market of paying customers are often neglected, and new treatments for them are rare. Data standards offer hope for cutting the cost and raising the efficiency... Read more »